Rationale: Activation of monocytes/macrophages by hyperlipidemia associated with diabetes mellitus and obesity contributes to the development of atherosclerosis. PKCδ (protein kinase C δ) expression and activity in monocytes were increased by hyperlipidemia and diabetes mellitus with unknown consequences to atherosclerosis. 
D
yslipidemia accompanying systemic metabolic diseases, such as metabolic syndrome and type 2 diabetes mellitus, is a major risk factor for the development of atherosclerosis. The accumulation of cholesterol and its oxidized products in the arterial wall stimulates an inflammatory process that recruits monocytes into the vascular wall where they differentiate into macrophages and become foam cells to form atherosclerotic plaques. 1 Hyperlipidemia can also induce monocytosis that can enhance the uptake and accumulation of monocytes into the vascular wall. 2 Macrophage turnover in the atherosclerotic plaque can also be important because a high turnover rate within 4 weeks has been reported. 3 The removal of macrophages from atherosclerotic plaque is mainly through apoptosis because their ability to egress is significantly reduced after differentiation into foam cells. 4 Studies from atherosclerotic regression models support that macrophage apoptosis is the major pathway for macrophage removal from the plaque. 5 However, recent studies suggested that macrophages in the arterial wall/plaque can proliferate. 3 In diabetes mellitus, multiple studies have shown that hyperglycemia and lipids modified by glycation (glyLDL [low-density lipoprotein]), oxidation (OxLDL), and acetylation (AcLDL) can activate monocytes and enhance their uptake into the arterial wall.
and oxidative stress. [8] [9] [10] [11] [12] Many reports have shown that in diabetic and insulin-resistant states, glucose and lipids, such as OxLDL, can activate PKC isoforms, especially the β isoform, to accelerate many pathological processes, including atherosclerosis. [11] [12] [13] [14] [15] In the present study, we characterize the ability of OxLDL and tumor necrosis factor α (TNFα) to activate PKCδ (protein kinase C δ) isoform and its effects on PKC isoform on monocyte/macrophage homeostasis in the vascular wall in the presence of obesity-induced insulin resistance and hypercholesterolemia. PKCδ isoform activation was studied because its expression and activity were found to be selectively increased in the monocytes by these conditions.
Methods

Animals
PKCδ flox/flox mice were generated, as described previously. 16 All protocols for animal use and euthanasia were reviewed and approved by the animal care committee of the Joslin Diabetes Center, in accordance with National Institutes of Health guidelines following the standards established by the animal welfare acts and by the documents entitled "Principles for Use of Animals" and "Guide for the Care and Use of Laboratory Animals."
Statistical Analysis
Comparisons of the 2 groups were made using a paired or unpaired t test as appropriate. Comparison among >2 groups was performed by a 1-or 2-way ANOVA followed by the post hoc analysis with a paired or unpaired t test to evaluate statistical significance between the 2 groups. Statistical significance was defined as P<0. 05 . In text and graphs, data were presented as the mean±standard error.
Detailed Materials and Methods are presented in the Online Data Supplement.
Results
Characterization of PKCδ Activation in Monocytes/ Macrophages of Rodent Models With Diet-Induced Hyperlipidemia and Diabetes Mellitus
PKC activities and the expressions of its isoforms were studied in peripheral blood mononuclear cells isolated from Zucker diabetic fatty (ZDF) rats that exhibit hyperlipidemia and hyperglycemia (Online Table I ) and in lean nondiabetic control rats. Total in situ PKC activities were increased by 2-fold in peripheral blood mononuclear cells from ZDF compared with nondiabetic control rats 
Novelty and Significance
What Is Known?
• Diabetes mellitus and insulin resistance associated with obesity can activate monocytes to increase inflammation and accelerate atherosclerosis.
• Hyperglycemia and elevated free fatty acids can induce monocyte to macrophage differentiation by increasing lipid synthesis and activating multiple isoforms of PKC (protein kinase C).
• Activation of PKCα and β isoforms in monocytes by diabetes mellitus can contribute to the accelerated atherosclerosis in diabetes mellitus. However, the role of PKCδ activation in monocytes on the severity of atherosclerosis has not been determined.
What New Information Does This Article Contribute?
• The PKCδ isoform is activated in monocytes/macrophages in rodent models of obesity-induced diabetes mellitus and insulin resistance; the PKCδ activation was replicated in cultured macrophages exposed to acetylated LDL (low-density lipoprotein) and oxidized LDL but not to elevated glucose concentrations.
• Deletion of PKCδ specifically in myeloid cells in ApoE −/− mice accelerated atherosclerosis and splenomegaly by inducing proliferation and decreasing apoptosis of the macrophage in the arterial wall and in the spleen.
• Activated PKCδ induced by elevated lipids and diabetes mellitus can phosphorylate PI3K to inhibit pAkt activation and increase apoptosis of macrophage in the arterial wall. • Abnormal lipids induced by diabetes mellitus and insulin resistance can elicit anti-inflammatory responses and inflammatory actions in macrophages, which in turn can affect atherosclerosis.
The effect of increased PKCδ expression and activity in monocytes in response to hyperlipidemia and diabetes mellitus on atherosclerosis was unknown previously. PKCδ expression and activity were increased in Zucker diabetic rats. Mice with selective deletion of PKCδ in myeloid cells were generated by breeding PKCδ flox/flox mice with LyzM-Cre and ApoE −/− mice (MPKCδKO/ ApoE −/− mice), and the mice were fed a high-fat diet. Mice fed high-fat diet exhibited hyperlipidemia, insulin resistance, and mild diabetes mellitus. MPKCδKO/ApoE −/− mice exhibited increased aortic atherosclerosis by 2-fold and splenomegaly versus control ApoE −/− mice fed high-fat diet. High-fat diet increased macrophage number in aortic plaques and spleens in MPKCδKO/ ApoE −/− versus ApoE −/− mice because of decreased apoptosis (62%) and increased proliferation (1.9-fold), and not because of monocyte recruitment, with parallel increases in expression of inflammatory cytokines. The increased macrophage accumulation in MPKCδKO/ApoE −/− mice was associated with elevated phosphorylation levels of the prosurvival cell-signaling proteins, Akt and FoxO3a, and with a reduction of the proapoptotic protein Bim. These changes were associated with PKCδ-induced inhibition of P85/PI3K. Development of atherosclerosis induced by insulin resistance and hyperlipidemia may be partially limited by PKCδ activation in monocytes. Figure 1 . Regulation of PKCδ (protein kinase C δ) isoform in monocytes/macrophages by hyperlipidemia, OxLDL, and lipopolysaccharides (LPS). A, PKC activity in peripheral blood mononuclear cells (PBMCs) was measured by in situ PKC assay (n=6 per group). B, Expression of PKCα, β, and δ in PBMCs from Zucker diabetic fatty (ZDF) rats or Zucker lean (ZL) control (Con) rats was determined by real-time polymerase chain reaction (qRT-PCR; n=4 per group). C, PKCδ expression in blood monocytes, neutrophils, B cells, and T cells of ZDF rats or Con rats was determined by flow cytometry (n=4 per group). D, PKCδ expression in spleen macrophages from mice fed with normal chow (NC) or high-fat diet (HFD). Mean fluorescence of PKCδ in spleen macrophages was determined by flow cytometry (n=5 per group). E, Bone marrow (BM) macrophages were stimulated with OxLDL (50 µg/mL) or LPS (100 ng/mL) for 4 h, and PKCδ gene expression was measured by qRT-PCR and normalized by 36B4. Con, n=10; OxLDL, n=10; LPS n=6. F and G, PKCδ protein expression in BM macrophages stimulated with OxLDL (50 µg/mL) or LPS (100 ng/mL) for 8 h was determined by Western blotting and normalized with GAPDH (n=4 per group). CPM indicates counts per minute; and LDL, low-density lipoprotein. October 27, 2017 (P<0.05; Figure 1A ). Expressions of PKC isoforms in peripheral blood mononuclear cells showed that PKCδ mRNA were significantly increased by 2.9±0.6-fold in ZDF compared with nondiabetic control rats ( Figure 1B ), but levels of PKCα or β isoforms were not changed ( Figure 1B) . PKC isoforms were also studied in circulating monocytes labeled with CD11b . These cells, costained with anti-PKCδ antibodies, indicated that the expression of PKCδ in monocytes was 3.5-, 4-, and 7-fold higher than in neutrophils, B cells, and T cells, respectively ( Figure 1C) . Compared with nondiabetic control rats, PKCδ expression in the circulating monocytes and T cells was increased by 40% and 57%, respectively, in ZDF rats but was not different in the circulating neutrophils and B cells. PKCδ protein expression was evaluated in spleen macrophages, which increased significantly by 50% in ApoE −/− mice on 16 weeks of high-fat diet (HFD) compared with normal chow (NC; P<0.05; Figure 1D ). Potential causes for the increased expressions of PKCδ in monocytes/macrophages because of hyperlipidemia and diabetes mellitus were studied using cultured bone marrow (BM) macrophages initially with OxLDL and lipopolysaccharides (LPS), which increased PKCδ mRNA by 2.1±0.1-and 2.2±0.2-fold, respectively, and protein levels by 2.4±0.2-and 2.8±0.2-fold, respectively ( Figure 1E through 1G ). Further analysis was performed with inflammatory cytokines that are reported to be elevated in diabetes mellitus, including TNF-α, interleukin 6 (IL-6), or AcLDL, which was used as a surrogate for modified LDL, such as glycated or oxidized LDL, or fatty acids, such as palmitic acid, oleic acid, or arachidonic acid, on PKCδ expression. The results showed that TNFα and AcLDL increased gene expressions of PKCδ in the macrophages by 2-fold, whereas IL-6 and fatty acids were ineffective (Online Figure I) . No differences were observed when macrophages were incubated with glucose levels of 5.6 or 25 mmol/L. PKC activities, measured by the translocation of PKCδ proteins from cytosol to cell membrane, were increased after stimulation with either OxLDL or LPS for 8 hours but not during the first 10 minutes. For positive control, the addition of phorbol-12-myristate-13-acetate (PMA) for 10 minutes increased the translocation of PKCδ to cell membrane by 5-fold (Online Figure II) . 
Characterization of MPKCδKO
Effect of PKCδ Deletion on Macrophage Expression of Inflammatory Cytokines and Functions
Activation of PKC by PMA in BM macrophages from ApoE −/− mice significantly increased the expression of proinflammatory cytokines IL-1B, MCP-1 (monocyte chemoattractant protein-1), TNFα, and anti-inflammatory cytokines, IL-1 receptor antagonist (IL-1RA) and arginase (Online Figure IV) . However, in macrophages from MPKCδKO/ApoE −/− mice, the effect of PMA on the expression of both pro-and anti-inflammatory cytokines was reduced dramatically (Online Figure  IV) . In contrast, the addition of LPS and OxLDL, which increased the expression of IL-1B, MCP-1, and TNFα production, did not result in differences in BM macrophages between ApoE −/− and MPKCδKO/ApoE −/− mice (Online Figure V) . Macrophage migration was evaluated by Transwell assay using vehicle, MCP-1, PMA, or PMA+MCP-1. Online Figure  VI showed that macrophages from MPKCδKO/ApoE −/− mice migrated faster (2-fold; P<0.05) than wild-type (WT) macrophages at basal level. MCP-1 increased macrophage migration in WT macrophages, which was inhibited by PKC activator PMA. Macrophages from MPKCδKO/ApoE −/− mice did not respond to PMA to inhibit the effects of MCP-1.
Macrophage phagocytosis, studied by the uptake of FITC (fluorescein isothiocyanate)-conjugated IgG-coated latex beads, did not exhibit changes between macrophages derived from ApoE −/− or MPKCδKO/ApoE −/− mice, either at basal level or after PMA treatment. Similarly, monocyte differentiation to macrophages, characterized by using GM-CSF and assessing the presence of CD11b, F4/80, and CD36, 17 was not different between WT and MPKCδKO/ApoE −/− mice (Online Figure 6D ). Monocyte/macrophage differentiation was further determined in vivo. Thioglycollate was injected intraperitoneally. After 3 days, the expression of CD11b, F4/80, and CD36 was assessed by flow cytometry in circulatory monocytes (PI − CD45 + CD115 + ) and peritoneal macrophages (PI − CD45 + CD115 + ) and was significantly increased when circulatory monocytes differentiated into peritoneal macrophages with the injection of thioglycollate, but their expression again was not different between ApoE −/− mice and MPKCδKO/ApoE −/− mice, either in circulating monocytes or in peritoneal macrophages (Online Figure VIE) .
Effect of PKCδ Deletion on Atherosclerosis in Mice That Were Fed an Atherogenic Diet and That Had Hyperlipidemia But no Diabetes Mellitus or Insulin Resistance
Nondiabetic and noninsulin-resistant MPKCδKO/ApoE −/− mice and ApoE −/− mice were studied after being fed an atherogenic diet (AD), which induced hypercholesterolemia. The body weight of MPKCδKO/ApoE −/− mice was slightly higher compared with ApoE −/− mice after 12 weeks of AD (Online Figure VIIA) . Mean blood pressure, fasting insulin, and intraperitoneal glucose tolerance test were similar between the 2 groups (Online Figure (Figure 2A and 2B) . However, the amount of atherosclerosis was similar in aortic roots (data not shown), but they were elevated by 3. Figure 2C ). The complexity of the atherosclerotic plaques, assessed by macrophage content (MAC2 [galectin 3] staining), increased by 1.7-fold in the aortic lesions from MPKCδKO/ApoE −/− mice versus ApoE −/− mice 
Macrophage Apoptosis and Proliferation in the Aorta
The paradoxical findings of decreased levels of circulating monocytes and elevated levels of macrophage content in the aortic wall suggested that turnover of macrophage could be changed in MPKCδKO/ApoE −/− mice. Macrophage apoptosis in atherosclerotic plaques, determined by TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling) and MAC2 staining, was significantly lower in the Figure 3B ). The extent of cellular proliferation was confirmed by the number of isolated aortic cells incorporating BrdU. The aorta from MPKCδKO/ ApoE −/− mice contained 2.3-fold more BrdU /CD11b-positive cells than ApoE −/− mice (P<0.05; Figure 3C ). The increase in BrdU + macrophages in the aortic wall could also be because of the recruitment of circulating BrdU + monocytes. However, pertussis toxin-an inhibitor of monocyte recruitment 18 reduced monocyte recruitment into the peritoneal cavity by 70% but did not reduce the elevation of BrdU + macrophages in the aorta of MPKCδKO/ApoE −/− mice versus ApoE −/− mice ( Figure 3C ). Figure XI) .
Inflammatory Cytokine Expression in the Aorta and Lipid Uptake Into Macrophages
PKC activation has been reported to regulate the uptake of LDL in monocytes via CD36, which can be important in the formation of foam cells. 19, 20 The uptake of AcLDL by peritoneal macrophages, characterized by using Alexa488-labeled AcLDL, did not differ between MPKCδKO/ApoE −/− and ApoE −/− mice (Online Figure XII) . 
Effect of HFD on ApoE
Mice
The severity of atherosclerosis in MPKCδKO/ApoE −/− mice on HFD was studied because HFD with 60% of calories from fat, unlike AD, induces obesity, insulin resistance, and hyperglycemia in addition to hyperlipidemia. 21 The body weight of MPKCδKO/ApoE −/− and ApoE −/− mice were similar either on NC or HFD for 16 weeks (Online Figure  XIIIA) , although HFD increased body weight significantly in both types of mice compared with NC. Plasma cholesterol and triglyceride levels were not different between the 2 groups of mice on NC, but cholesterol (490.0±12.6 versus 577.3±21. Figure XIIID) . Blood pressure (Online Figure  XIIIE) , intraperitoneal insulin tolerance test, and intraperitoneal glucose tolerance test (Online Figure XIV) were similar between the 2 groups of mice on HFD, but HFD increased blood glucose levels at 30 minutes to >500 mg/ dL, indicating mild diabetes mellitus.
Circulating monocyte levels were not different on NC, but their levels in MPKCδKO/ApoE −/− mice fed with HFD for 4 weeks showed a 55% decrease (P=0.08; Figure 4A 
Severity of Atherosclerotic Lesions and Macrophage Contents on HFD
After 16 weeks of HFD, even with decreased levels of plasma cholesterol, the extent of the atherosclerotic plaque area increased by 1.6-fold in the aorta of glucose intolerant MPKCδKO/ApoE −/− compared with ApoE −/− mice (5.62±0.64% versus 3.57±0.35%; P<0.01; Figure 5A through 5C). The collagen content also increased in the plaque of MPKCδKO/ApoE −/− mice, but the difference was not significant ( Figure 5B and 5D ). The content of macrophages, estimated in the plaque of HFD MPKCδKO/ApoE −/− mice by MAC2 staining, was 48% greater than HFD ApoE −/− mice (P<0.05; Figure 5E and 5F).
Analysis of Macrophage Apoptosis in the Aortic Plaques on HFD
PKCδ activation is known to induce apoptosis in multiple cell types. [22] [23] [24] [25] Therefore, macrophage apoptosis was compared in the aortic plaque of MPKCδKO/ApoE −/− and ApoE −/− mice, by MAC2 and TUNEL double staining. The results showed that the number of macrophages exhibiting apoptosis was decreased by 42% in MPKCδKO/ApoE −/− compared with ApoE −/− mice on HFD (P<0.05; Figure 6A ). The proliferation of macrophages, as determined by MAC2 and Ki67 double staining, increased by 2.6-fold in the aortic plaque of MPKCδKO/ApoE −/− compared with ApoE −/− mice on HFD (12.9±2.5 versus 5.1±1.1 per section; P<0.05; Figure 6B ). The differences in apoptosis in macrophages in cultured BM macrophages derived from MPKCδKO/ApoE −/− versus ApoE −/− mice were also studied. By withdrawing growth factor or OxLDL, plus a low dose of thapsigargin, an inducer of endoplasmic reticulum stress and a method to induce macrophage apoptosis, 26 BM macrophages from MPKCδKO/ApoE −/− mice exhibited ≈50% less apoptosis than those from ApoE −/− mice (P<0.05; Figure 6C ). 
Characterization of Plaque Stability
Characterization of Akt Phosphorylation, and Its Signaling in Macrophages
PKC activation can inhibit Akt phosphorylation (pAkt) and its signaling of several growth factors to increase apoptosis. 10, 24 Basal pAkt levels were 5.3-fold higher in MPKCδKO/ ApoE −/− ( Figure 7A ) compared with ApoE −/− mice. Activation of PKC with PMA significantly inhibited pAkt (by 78%) in ApoE −/− mice, but in PKCδ deficient macrophages, pAkt levels remained higher than cells from ApoE −/− mice after PMA stimulation (P<0.01). Incubation of BM macrophages with thapsigargin and OxLDL for 3 hours inhibited pAkt by 63% in control macrophages, but their effect on pAkt in MPKCδKO/ ApoE −/− mice was reduced only by 12% (P<0.05; Figure 7B ). October 27, 2017
Thapsigargin dramatically inhibited pAkt, and its effects were further enhanced by OxLDL in ApoE −/− macrophages ( Figure 7C ). These data were consistent with a previous report that OxLDL can enhance low-dose thapsigargin-induced macrophage apoptosis. 26 In contrast, OxLDL did not enhance thapsigargin's inhibition effects on pAkt in PKCδ-deficient macrophages ( Figure 7C ). The pAkt levels in the splenic macrophages, determined by flow cytometry, showed that pAkt levels were increased by 52% in macrophages from MPKCδKO/ ApoE −/− compared with ApoE −/− mice ( Figure 7D ). Levels of Akt in the macrophage cell line Raw264.7 were reduced (by 92%) by lentivirus containing Akt shRNA, compared with control shRNA, which paralleled increases in cellular apoptosis, as determined by annexin V and propidium iodide (PI) staining by 35%. Compared with cells grown in medium containing serum, withdrawing growth factor increased apoptosis by 266% in macrophages from ApoE −/− mice in contrast to 46% inhibition in macrophages from MPKCδKO/ApoE −/− mice. Inhibition of Akt by wortmannin-a specific inhibitor of PI3 kinase-further increased macrophage apoptosis by 400% in both type of cells, indicating that inhibition of Akt activation will induce apoptosis in macrophages (Online Figure XVIC) .
The effect of deleting PKCδ on the phosphorylation of P85-a subunit of PI3K-was studied because the PKC-induced phosphorylation of P85 has been reported to inhibit the activation of PI3K.
9,27 PKC-induced phosphorylations of P85/PI3K of macrophages between ApoE −/− and PKCδ-deficient mice were identified by antiphospho-motif antibody, which recognized PKC phosphorylation sites on P85/PI3K. 28 PMA increased P85 phosphorylation by 1.6-fold in ApoE −/− macrophages ( Figure 7E ). In contrast, PMA-induced P85 phosphorylation increased by <10% ( Figure 7E ) in MPKCδKO/ApoE −/− mice. Effects of PKCδ to inhibit Akt activation through ser/ thre phosphorylation of IRS2 were also studied because macrophages mainly expressed IRS2. 29 We have previously identified that Ser343 on IRS2 could be phosphorylated by PKC activation to inhibit insulin-induced pAkt in endothelial cells. 8, 30 In the macrophages, the phosphorylation of Ser343 on IRS2 was increased by PKC activation using PMA in WT macrophages but was not observed in PKCδ-deficient macrophages (Online Figure XVII) . One downstream action of pAkt is to inhibit transcriptional activities of FoxO by its phosphorylation levels. 31 Parallel with increased pAkt, FoxO3a phosphorylation at threonine 32 was increased by 42% in PKCδ-deficient macrophages compared with ApoE −/− mice ( Figure 7F ; P<0.01). Bim-a BH3-only member of BCl2-is a downstream target of FoxO3a activation. 28 Consistent with increased phosphorylation of FoxO3a, Bim expression was decreased by 41% in BM macrophages from MPKCδKO/ ApoE −/− compared with ApoE −/− mice (P<0.05; Figure 7F ).
Similarly, we confirmed the reduction of Bim expression in circulating monocytes (CD45 + CD11b + Ly6G − ) positive to anti-Bim antibody, which decreased by 50% in monocytes from MPKCδKO/ApoE −/− compared with ApoE −/− mice (Online Figure XVIII) . Further, PKCδ was overexpressed by 6.8-fold in Raw 264.7 cells by lentivirus containing PKCδ full-length plasmid. In parallel with PKCδ overexpression, the expression of Bim was increased by 3.8-fold, whereas the level of pAkt and p-FoxO3a was decreased by 53% and 39%, respectively (P<0.05; Online Figure XIX) . Overexpression of PKCδ also inhibited cell proliferation by 72% and increased cell apoptosis by 67% (P<0.05, Online Figure XIX) . When the expression of PKCδ in the macrophages of MPKCδKO/ApoE −/− mice was reconstituted by infection with lentivirus containing full-length plasmid of PKCδ, which increased its expression by 2-fold, Akt and FoxO3a phosphorylation levels were significantly decreased after treatment with thapsigargin plus OxLDL (Online Figure XXI) . s Modified Eagle's medium] containing 1% fetal bovine serum (FBS) and 2% conditioned L929 medium for 16 h) and after PKC (protein kinase C) activation induced by 100 nmol/L phorbol-12-myristate-13-acetate (PMA) was determined at indicated times (n=4 per group). B and C, pAkt after Thpn (0.25 uM) plus OxLDL (50 µg/mL) stimulation in macrophages cultured in growth medium (DMEM with 10% FBS and 20% conditioned L929 medium) for indicated times (B, n=5-7 per group) or after OxLDL (50 µg/mL), or Thpn (0.25 uM), or OxLDL plus Thpn stimulation for 3 h (C, n=6 per group). D, pAkt in isolated spleen macrophages, which were measured by flow cytometry (ApoE −/− , n=7; MPKCδKO/ApoE −/− , n=6). E, P85 phosphorylation was determined by antibody that recognizes PKC phosphorylation sites (n=3 per group). F, FoxO3a phosphorylation and Bim expression in macrophages starved with DMEM containing 1% FBS and 2% condition L929 medium for 16 h (n=8 per group). LDL indicates low-density lipoprotein. October 27, 2017
Effect of AD or HFD Diet on Monocyte Expansion in the Spleen
Spleen-to-body ratio by weight was studied in MPKCδKO/ ApoE −/− mice because of the splenomegaly that was noted when these mice were fed chronically with either AD or HFD diet ( Figure 8A ). Interestingly, no differences in spleen size between MPKCδKO/ApoE −/− and ApoE −/− mice were observed while they were fed with NC ( Figure 8B ). However, after 8 and 12 weeks of AD, the spleen body ratios were higher in MPKCδKO/ApoE −/− mice than that in ApoE −/− mice by 1.6-and 2.5-fold, respectively (P<0.05; Figure 8A and 8B). Hematoxylin and eosin staining showed that the red pulp of spleen from MPKCδKO/ApoE −/− mice was greatly expanded, and immunofluorescence staining for F4/80 demonstrated that macrophage content in the red pulp was significantly more than ApoE −/− mice (Online Figure XXII) , which was confirmed by a 2-fold increase of F4/80 positive cells in the spleen, per flow cytometry, in MPKCδKO/ApoE −/− compared with ApoE −/− mice ( Figure 8C ). However, on HFD, the weight of spleen of MPKCδKO/ApoE −/− mice was the same as ApoE −/− mice after 4 weeks and was 1. 
Analysis of Macrophage Proliferation and Apoptosis in the Spleen
Apoptosis in the splenic macrophages was determined by labeling with antibodies to CD45, F4/80, annexin V, and PI, which showed that the apoptosis was decreased by 57% in cells from MPKCδKO/ApoE −/− compared with ApoE −/− mice ( Figure 8D ; P<0.01). The extent of macrophage proliferation, assessed by Ki67 incorporation, was markedly increased in the spleen of MPKCδKO/ApoE −/− compared with ApoE −/− mice (Online Figure XXIVA) . Further, the percentage of cells that incorporated EDU (5-ethynyl-2´-deoxyuridine) and positive for F4/80 + increased by 2.1-fold in MPKCδKO/ApoE −/− compared with ApoE −/− mice (9.3±1.5% versus 4.4±0.8%; P<0.05; Figure 8E) . Lastly, the cell cycle of isolated splenocytes in the G0/G1 phase was decreased (75.93±3.59% versus 86.00±1.85%; P<0.05) and in the S phase was increased ( 
Discussion
Our initial observation showed that in ZDF rats-a model of hyperlipidemia, obesity, diabetes mellitus, and insulin resistance-PKC, especially the δ isoform in the monocytes, was activated and overexpressed. This is consistent with previous reports that several PKC isoforms α, β, and δ are preferentially activated in monocytes and vascular cells by diabetes mellitus and insulin resistance. Overexpression of PKCβ in macrophages exhibited an increase in fetal bovine serum-stimulated proliferation by 80% (Online Figure XX) . In contrast, PKCδ activation, induced by lipids, exhibited proapoptotic actions in monocytes/macrophages, which reduced inflammation and severity of atherosclerosis in insulin-resistant or hyperlipidemic states.
The elevation of PKCδ isoform expression in peripheral blood mononuclear cells of diabetic and hyperlipidemic rodents is likely because of increased lipid levels or inflammatory cytokines because elevated glucose levels were ineffective. The ability of altered lipids (OxLDL and AcLDL) or cytokines (TNFα) to increase the expression of PKCδ is consistent with previous reports that oxidative stress or inflammation can increase its expression via activation of SP1 promoter 5′ regions of PKCδ gene. 32 The surprising results are that PKCδ deletion targeted to the macrophages increased the severity of atherosclerosis in MPKCδKO/ApoE −/− mice, which occurred even in the presence of lower total circulating monocytes, cholesterol, and triglycerides levels in MPKCδKO/ApoE −/− mice. Initially, we assumed the activation of PKCδ in the monocyte could contribute to the enhancement of atherosclerosis caused by insulin resistance in diabetes mellitus, possibly because of PKCδ activation by angiotensin. The specificity of the effect is mainly attributed in the monocyte because no changes in PKCδ expression were observed in the T and B cells of PKCδ KO/ApoE −/− mice. However, the contribution of neutrophils to the extent of atherosclerosis will need to be clarified because PKCδ expression was decreased in the neutrophils of MPKCδKO/ApoE −/− mice. The pathology of the atherosclerotic plaques in MPKCδKO/ ApoE −/− mice indicated that the increased severity of atherosclerosis was related to elevated number of macrophages and decreased SMCs and collagen content. These changes suggest that the plaque may be less stable than those in ApoE −/− mice. The increased number of macrophages in the atherosclerotic plaque was likely responsible for the observed elevated expression of inflammatory cytokines IL-2, CCL5, and CXCL9 in the aorta of MPKCδKO/ApoE −/− mice. Interestingly, results from the in vitro studies showed that PKCδ isoform deletion decreased the productions of both pro-and anti-inflammatory cytokines in response to PKC activators but was not changed to LPS. However, deletion of PKCδ isoform in monocytes did elevate macrophage migration, which indicates increased macrophage activation. Thus, the elevations of inflammatory cytokines in vivo are likely the results of increased number of activated macrophages in the aortic wall.
Surprisingly, these findings suggested that the mechanisms for the increased accumulation of macrophages in the aortic plaque in MPKCδKO/ApoE −/− mice were the result of elevated proliferation and decreased apoptosis, rather than monocyte/macrophage differentiation or monocyte uptake. Most studies in obesity-related or diabetic models of atherosclerosis have shown that elevated levels of circulating monocytes and their uptake are the cause for increased macrophage in the aortic wall. 33 However, the present study showed that homeostasis of macrophage turnover in the aortic wall in association with hyperlipidemic states could be important for the severity of atherosclerotic plaques. The increases in PKCδ expression and activation induced by oxidized or glycated lipids can enhance apoptosis and inhibit proliferation, thus lowering macrophage number and inflammatory cytokine levels. These effects of PKCδ on monocytes/macrophages are consistent with several other studies on its effects on inflammatory and immune cells. For example, activation of PKCδ has been reported to decrease B-cell proliferation and associated with splenomegaly and autoimmune diseases. [34] [35] [36] [37] Elevation of PKCδ in capillary pericytes enhanced its apoptotic rates and caused retinopathy. 22 Our results showed that PKCδ deletion or reduction promoted macrophage survival in the plaque and accelerated the development of atherosclerosis. In addition, the stability of the plaque may be decreased in MPKCδKO/ApoE −/− versus ApoE −/− mice with more macrophages and less VSMCs (vascular smooth muscle cells). PKCδ activation induced specifically by hyperlipidemia, and not hyperglycemia, probably has a critical role in modulating the progression of early atherosclerotic lesions.
The mechanism by which PKCδ is regulating macrophage proliferation and apoptosis is related to the inhibition of Akt, which is not surprising because activation of Akt is known to be antiapoptotic and to enhance proliferation in many cells, including macrophages. 38 Our results supported this mechanism because pAkt was higher in PKCδ-deficient macrophages and was inhibited by reconstituting PKCδ in the PKCδ-deficient macrophages. The target of PKCδ activation October 27, 2017 to inhibit pAkt is likely related to the phosphorylation of IRS2/PI3 kinases, reported in endothelial cells. 8, 9 Previously, we showed that PKCδ can decrease pAkt by phosphorylating ser343 on IRS2-the predominant mediator of insulin receptor's actions in monocytes-and P85. We showed that phosphorylation of FoxO3a was increased in PKCδ-deficient macrophages, which resulted in reduced expression of proapoptotic gene Bim. Thus, elevated glycated or oxidized lipids caused increases in PKCδ expression and activation to regulate apoptosis through IRS2/PI3K-Akt-FoxO3a-Bim pathway in macrophages.
The modulating effect of PKCδ on monocyte/macrophage survival and proliferation is not limited to the vascular wall, as shown by splenomegaly in MPKCδKO/ApoE −/− mice fed only on HFD and AD. The splenomegaly in MPKCδKO/ ApoE −/− mice is responsible for the decrease in circulating neutrophils, T cells, and B cells because their blood levels were not diminished after 4 weeks on HFD, and no changes were noted in the BM. These findings have emphasized the important contributions of macrophage turnover in the arterial wall on the severity of atherosclerosis. There is substantial evidence to support the idea that macrophages can proliferate in the arterial wall. 3, 18, 39 The proliferation of macrophages in the atherosclerotic plaques in humans and animals has been reported by several groups. 3, 18, 39 Our study clearly demonstrated that macrophages can proliferate in the aortic wall with significant elevation of Ki67 and MAC2 double positive cells in the MPKCδKO/ApoE −/− mice versus ApoE −/− mice. To exclude the possibility that PKCδ deletion affected hematopoiesis, we examined hematopoietic stem cells, monocytes, neutrophils, B cells, and T cells in BM, which did not differ in the 2 groups of mice under NC or HFD after 4 weeks ( Figure 4E and 4F ). This finding suggests that PKCδ deletion targeted to the monocyte/macrophages did not affect the development of monocytes, neutrophils, B cells, and T cells in the BM. This is not surprising because previous reports have shown that whole body knockout of PKCδ resulted in decreases in B-cell apoptosis with increased BM and circulating B-cell number, whereas leaving T cells and other myeloid cells unchanged. 35 Thus, we think the specific decreases in B and T cells in circulation in MPKCδKO/ApoE −/− mice were mainly because of the function of splenomegaly, which is known to increase the uptake and clearance of circulating blood cells, likely because of increased monocytes or macrophages in the red pulp of the spleen to cause increased retention of all cell types, even platelets. Multiple studies have shown the surgical removal of the enlarged spleen will rapidly return the circulatory cells to normal levels. 40 It is commonly found that BM progenitor cells of these circulatory cells are not abnormal unless the basic pathogenesis of the disease also affected those BM stem cells, such as those involved in autoimmune diseases.
In summary, these findings clarify for the first time that PKCδ activation in monocytes/macrophages induced by hyperlipidemia in insulin resistance and diabetes mellitus could be a negative modulator of macrophage number in the vascular wall and systemic tissues probably mediated by the inhibition of pAkt. Inhibiting PKCδ to improve insulin resistance and microvascular complications may have contrary effects on the progression of atherosclerosis in the hyperlipidemic state induced by diabetes mellitus and insulin resistance.
